PHARMACOGENETIC TESTING
Clinical trials for PHARMACOGENETIC TESTING explained in plain language.
Never miss a new study
Get alerted when new PHARMACOGENETIC TESTING trials appear
Sign up with your email to follow new studies for PHARMACOGENETIC TESTING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study aims to predict dangerous side effects of common breast cancer drugs
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at 100 breast cancer patients taking CDK4/6 inhibitor drugs. Researchers want to find genetic and blood markers that can predict who will have bad side effects or not get enough benefit from the medication. The goal is to help doctors choose safer and more effect…
Matched conditions: PHARMACOGENETIC TESTING
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Genetic testing aims to improve drug satisfaction in underserved communities
Knowledge-focused OngoingThis study looks at whether giving patients genetic test results early can help doctors choose better medications. About 492 adults with at least three prescriptions will be randomly assigned to get immediate or delayed genetic testing. The goal is to see if this approach improve…
Matched conditions: PHARMACOGENETIC TESTING
Phase: NA • Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC